A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)

• Main Authors: Chong Guan, Ng, Aya Ahmed, Abousheishaa, Sue Yin, Low, Nor Zuraida, Zainal, Kai Shin, Thong, Azizul, Awaluddin, Tsui Huei, Loo, Sapini, Yacob, Nik Ruzyanei, Nik Jaafar, Nur Iwana, Abdul Taib, Nurul Ain, Mohamad Kamal, Fuad, Ismail, Wan Zamaniah, Wi
• Format: Article
• Language: English
• Published: The Asian Pacific Journal of Cancer Prevention (APJCP) 2023
• Subjects: RZ Other systems of medicine
• Online Access: http://ir.unimas.my/id/eprint/42713/3/A%206-Month.pdf; http://ir.unimas.my/id/eprint/42713/; https://journal.waocp.org/?sid=Entrez:PubMed&id=pmid:37642043&key=2023.24.8.2583

Objective: Vortioxetine is a monoaminergic drug with a novel multimodal mechanism of action. We investigated its efficacy on depressive symptoms, cognitive function, and quality of life among cancer patients.Methods: In this multicenter, open-label, single-arm, observational study, patients received...